Showing results (221-230 of 233) with videos related to

Sort By:
Pageof 24
Nature Communications|August 10, 2019
Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptorBahareh Eftekharzadeh, Varuna C Banduseela, Giulio Chiesa, et al.
Nature Communications|October 9, 2019
Author Correction: Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptorBahareh Eftekharzadeh, Varuna C Banduseela, Giulio Chiesa, et al.
Breast (Edinburgh, Scotland)|January 26, 2024
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?Xuhui Guo, Jiao Zhang, Xilong Gong, et al.
The Oncologist|September 16, 2017
Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for ChemopreventionFei Wang, Liyuan Liu, Shude Cui, et al.
Genome Medicine|January 12, 2024
Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapyGengshen Yin, Liyuan Liu, Ting Yu, et al.
Journal of Cellular Biochemistry|February 27, 2019
Association of PTPN1 polymorphisms with breast cancer risk: A case-control study in Chinese femalesShuya Huang, Liyuan Liu, Yujuan Xiang, et al.
British Journal of Clinical Pharmacology|May 8, 2014
Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseasesWei-Jian Pan, Kathleen Köck, William A Rees, et al.
Nature Cancer|February 5, 2022
The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancerJiang Liu, Liyan Lao, Jianing Chen, et al.
Science China. Life Sciences|May 17, 2022
A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancerChang Gong, Ziliang Cheng, Yaping Yang, et al.
Frontiers in Endocrinology|June 26, 2020
Erratum: Addendum: Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case-Control Study in Chinese WomenYujuan Xiang, Wenzhong Zhou, Xuening Duan, et al.
Pageof 24